An in vivo NanoBiT-based pseudoviral biosensor for real-time monitoring of SARS-CoV-2 spike/hACE2 interactions and therapeutic screening
Analytica Chimica Acta · 2025
DOI: 10.1016/j.aca.2025.344623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Cheng-Han Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300, Taiwan. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus, Biosensing Techniques, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Science and Technology Council, National Yang Ming Chiao Tung University, Ministry of Education.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 infects host cells through its trimeric surface spike protein, which binds to the human angiotensin-converting enzyme 2 (hACE2) receptor. The spike/hACE2 interaction is a critical target for therapeutic intervention against COVID-19. Although existing hACE2 transgenic mouse (TG) models facilitate studies of viral pathogenesis, they lack the capacity for real-time, non-invasive monitoring of viral entry events in vivo. To address this limitation, we developed a novel in vivo NanoLuc Binary Technology-based pseudoviral biosensor optimized for dynamic visualization of spike-hACE2 binding in live animals. Genetically engineered LgBiT-fused hACE2 (LgBiT-hACE2) mice and a pseudovirus tagged with SmBiT-fused spike protein were developed. Upon spike-hACE2 binding, Nanoluciferase reconstitution generated quantifiable bioluminescent signals detectable within 6 h post-infection. Quantitative bioluminescence imaging using an in vivo imaging system enabled the visualization of virus infection in the LgBiT-hACE2 mouse model. Furthermore, baicalein and baicalin, two active flavonoid compounds derived from Scutellaria baicalensis, were identified as potent inhibitors for the viral spike and the hACE2 protein, respectively. Combined treatment yielded up to 90 % inhibition of spike/hACE2 interaction in vivo. This study presents an innovative in vivo biosensing model to non-invasively quantify virus-host interactions and evaluate the efficacy of spike-targeted antiviral agents under physiologically relevant conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300, Taiwan.
- Division of Pulmonary Medicine, Department of Internal Medicine, Tungs' Taichung Metro Harbor Hospital, Taichung, 400, Taiwan.
- Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300, Taiwan; Center for Intelligent Drug Systems and Smart Bio-devices (IDS(2)B), National Yang Ming Chiao Tung Univers…
Förderung
- National Science and Technology Council
- National Yang Ming Chiao Tung University
- Ministry of Education
Zitieren
APA
Lin, C. H., Lin, M. W., Yang, X. R., Chiang, H. H., Wu, T. H., Tsai, C. H., & Lin, C. S. (2025). An in vivo NanoBiT-based pseudoviral biosensor for real-time monitoring of SARS-CoV-2 spike/hACE2 interactions and therapeutic screening. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344623
Vancouver
Lin CH, Lin MW, Yang XR, Chiang HH, Wu TH, Tsai CH, et al. An in vivo NanoBiT-based pseudoviral biosensor for real-time monitoring of SARS-CoV-2 spike/hACE2 interactions and therapeutic screening. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2025.344623
BibTeX
@article{Lin2025,
author = {Lin, Cheng-Han and Lin, Meng-Wei and Yang, Xin-Rui and Chiang, Hua-Hsin and Wu, Ting-Hsuan and Tsai, Chin-Hung and Lin, Chih-Sheng},
title = {An in vivo NanoBiT-based pseudoviral biosensor for real-time monitoring of SARS-CoV-2 spike/hACE2 interactions and therapeutic screening},
journal = {Analytica Chimica Acta},
year = {2025},
doi = {10.1016/j.aca.2025.344623}
}
EUVIMED